Agoracom Blog Home

Archive for the ‘Datametrex AI Limited’ Category

Datametrex AI: Illuminating the Future of Business Intelligence and Analytics

Posted by Paul Nanuwa at 1:22 PM on Wednesday, January 10th, 2024

In a world dominated by data, Datametrex AI emerges as a visionary force, navigating the realms of business intelligence (BI), artificial intelligence (AI), and analytics with unprecedented precision. This article explores the positive industry outlook, intertwining it with Datametrex AI’s strategic trajectory and its ‘FLASH’ milestones that illuminate the company’s journey in the ever-evolving intelligence landscape.

Introduction:

As the sun rises on the landscape of business intelligence and analytics, Datametrex AI stands at the forefront, casting a bright light on the industry’s optimistic trajectory. In a world where BI, AI, and analytics converge, Datametrex AI’s journey is not just noteworthy; it’s illuminating. Let’s delve into the core of this intelligence symphony and discover how Datametrex AI is orchestrating the future.

Industry Outlook and Datametrex AI’s Trajectory:

The article reflects on the buoyant trends within the BI and analytics realm, showcasing how Datametrex AI strategically positions itself in this trajectory. It’s not just about keeping pace; it’s about leading the way into a future where data is not just analyzed but truly understood.

Voices of Authority:

Industry leaders echo Datametrex AI’s strategic brilliance. Their quotes resonate with the company’s direction, underlining not just its significance but its pivotal role in shaping the industry narrative. Datametrex AI doesn’t follow; it guides.

Datametrex AI’s FLASH Highlights:

Unveiling the ‘FLASH’ milestones, this section encapsulates Datametrex AI’s pivotal achievements such as bringing AI & GPT to the masses by officially launching its AI & GPT software, AnalyticsGPT.

AnalyticsGPT scans vast data streams from social media, news, blogs, forums, messengers, and more, making predictive analytics easily accessible. This software is designed to empower businesses with the ability to harness the power of AI for data analysis, research and discovery. The underlying AnalyticsGPT technology was developed in conjunction with and used by the U.S. and Canadian Military for defense initiatives and is characterized by its robustness, reliability, and precision. Enterprises now have access to the new AnalyticsGPT platform, allowing them to leverage this intuitive, user-friendly interface for their own business needs.

Real-world Relevance:

Translating complex contributions into relatable impacts, this section paints a vivid picture of Datametrex AI’s real-world relevance. Analogies and examples become the canvas, where investors can see how Datametrex AI’s innovations translate into tangible benefits.

Looking Ahead with Datametrex AI:

Casting a glance into the future, this section intertwines Datametrex AI’s forward-looking goals with the industry’s optimistic forecast. Datametrex AI isn’t just adapting; it’s pioneering the next chapter in intelligent solutions, inviting investors to be a part of this transformative journey.

Conclusion:

In conclusion, Datametrex AI isn’t just a participant; it’s a luminary in the expansive landscape of BI, AI, and analytics. This article serves as an invitation for investors to embark on a deeper exploration, showcasing Datametrex AI’s promising position in an industry marked by growth, innovation, and the relentless pursuit of understanding data like never before.

YOUR NEXT STEPS

Visit $DM HUB On AGORACOM: https://agoracom.com/ir/DatametrexAI

Visit $DM 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/DatametrexAI/profile

Visit $DM Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/DatametrexAI/forums/discussion

Watch $DM Videos On AGORACOM YouTube Channel:
https://www.youtube.com/@AGORACOMIR/playlists

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) . As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients. In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations. These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor. Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions

VIDEO – AnalyticsGPT: Unleashing the Power of AI Insights – Episode Two

Posted by Aidi Munoz at 4:05 PM on Monday, August 28th, 2023

Discover the future of artificial intelligence with our captivating video series, “AnalyticsGPT,” presented by AGORACOM in collaboration with Datametrex. As the world embraces the AI revolution, investors seek out genuine AI companies amid the sea of contenders. Enter Datametrex (DM: TSXV) (DTMXF: OTCQB), a frontrunner in AI solutions for governments and corporations worldwide, including heavyweights like the Canadian government, Samsung, and Ford.

To bridge the gap between AI and investors, we proudly present “AnalyticsGPT.” This engaging multi-video series delves deep into the AI landscape, featuring enlightening conversations with CEO Marshall Gunter, a distinguished AI expert. Join us on an exploration of the ground-breaking AnalyticsGPT platform, designed to empower users across diverse backgrounds to effortlessly engage with AI models. Gain access to the immense power of AI without the need for specialized expertise – a monumental leap for businesses large and small.

In “AnalyticsGPT: Unleashing the Power of AI Insights” – Episode Two, we revisit the triumph of Episode One and unveil the next level of AnalyticsGPT. CEO Marshall Gunter sheds light on the imminent launch of this revolutionary platform, designed to scale up and accommodate the dynamic demands of today’s AI-powered landscape. Delve into the core strategies that drive AnalyticsGPT’s expansion – from targeted marketing efforts aimed at SMEs to on-air television segments and hands-on demonstrations.

Witness the paradigm shift in data analysis as AnalyticsGPT propels businesses toward real-time insights, supercharging decision-making, market expansion, brand recognition, and more. With AnalyticsGPT, the future of AI-driven insights is here, transforming businesses into industry pioneers and catalyzing success on a global scale.

Join us in uncovering the transformative capabilities of AnalyticsGPT.

VIDEO – Datametrex Reports $10.4m In Net Earnings On $29.5M In Revenue For H1-2021

Posted by AGORACOM-JC at 10:56 AM on Monday, August 16th, 2021
This image has an empty alt attribute; its file name is DM-square.jpg

When it comes to small-cap companies, tech-focused Datametrex AI (DM: TSXV) (D4G: FSE) (DTMXF: OTCQB) is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.

In our newest interview with Datametrex, we sit down with CEO Marshall Gunter to discuss the company’s explosive H1-2021.  

Financial Highlights include:  

  • Revenue of $29,494,191 compared to revenue of $2,763,796 (same period 2020)
  • Net earnings of $10,410,485 compared to ($1,590,239).
  • EBITDA of $12,250,211 compared to ($1,197,679).
  • Cash balance significantly increased to $10,555,375 from $1,971,987 end of 2020.

And if that’s not enough… the company recently announced that passing 2nd round of scrutiny on a $40 Million AI bid.

This interview is a MUST WATCH. Sit back, relax and watch below.

VIDEO – Datametrex $DM.ca $DTMXF CEO Talks Record-Breaking Q1 2021, AI Business, & More $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 12:08 PM on Monday, May 31st, 2021
This image has an empty alt attribute; its file name is DM-square.jpg

When it comes to small-cap companies, tech-focused Datametrex AI is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.

In our newest interview with Datametrex, we sit down with CEO Marshall Gunter to discuss the company’s record-breaking Q1 2021, their explosive AI business, their incredibly successful foray into the COVID-19 market, and more. 

  • Record Q1 Revenue of $19.04 Million up 2,253%
  • Record Adjusted EBITDA of $10.68 Million up 1,548%
  • Net Earnings of 9,560,351 up 1,425%

Check out the interview down below.\

VIDEO – Datametrex $DM.ca $DTMXF CEO Talks Record-Breaking FY2020 with $12.3M In Revenue, Covid-19 Test Kits and More $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:12 PM on Friday, April 30th, 2021

When it comes to small-cap companies, tech-focused Datametrex AI is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.

Financial Highlights for year ending December 31, 2020:

  • Revenue of $12.3M vs. $3.4M for FY 2019
  • An increase of 264%

We sat down with CEO Marshall Gunter to discuss these highlights, the COVID-19 landscape, telemedicine, 2021 plans, and more.

Check out the interview down below.

Datametrex $DM.ca $DTMXF Announces OTCQB Listing $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 10:54 AM on Monday, April 19th, 2021
Datametrex ai logo 500x172 400 138
  • Company’s common shares will begin trading on the OTCQB® Venture Market (“OTCQB”) today, April 19, 2021 under the current stock symbol “DTMXF”
  • Marshall Gunter, CEO of Datametrex AI Limited, “With the Company’s shares now quoted on the OTCQB, it will enhance our visibility and make the Company’s shares available to a much larger group of U.S. investors. “

Toronto, Ontario–(Newsfile Corp. – April 19, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that after a successful application process for the OTCQB® Venture Market (“OTCQB”), the Company’s common shares will begin trading on the OTCQB today, April 19, 2021, at the opening of the market under the current stock symbol “DTMXF” and will remain listed on the TSX Venture Exchange under the ticker symbol “DM”.

Existing U.S. shareholders of Datametrex AI Limited shares, previously quoted on the OTC® Pink Open Market, will now be quoted on the OTCQB without any further action needed.

Marshall Gunter, CEO of Datametrex AI Limited, “With the Company’s shares now quoted on the OTCQB, it will enhance our visibility and make the Company’s shares available to a much larger group of U.S. investors. The quotation on the OTCQB is anticipated to enhance liquidity by providing current and prospective investors with an easily accessible and transparent trading platform where they go and obtain Real Time quotes and market information.”

About OTCQB

The OTCQB® Venture Market is the premier marketplace for entrepreneurial and development stage US and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. The ability to have the Company’s shares electronically transferred between brokerages in the US is significantly more convenient and reduces the costs incurred in trading shares. When shares are able to trade electronically, existing investors benefit from greater liquidity and execution speeds, while opening the door to new investors that may have been previously restricted from the Company’s shares.

To read more, click here.

Datametrex $DM.ca Secures Authorization by Health Canada for PCL COVID19 Rapid Antigen Test Kit $DTMXF $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 1:58 PM on Tuesday, March 23rd, 2021
Datametrex ai logo 500x172 400 138

*PCL Antigen has a test sensitivity of 94.29% and the test kits are suitable for point of care tests. No extra equipment is needed.

*They are simple to use, and results are available in 10 minutes. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

Toronto, Ontario–(Newsfile Corp. – March 23, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that Heath Canada (“HC”) has approved the PCL Inc.’s (“PCL”) COVID19 AG Rapid test kit (“PCL Antigen”), an antigen point-of-care rapid test device under the Interim Order (“IO”) Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19. Datametrex made an application for the PCL Antigen under IO on August 24, 2020, Respecting the Importation and Sale of Medical Devices for use in relation to COVID-19 pursuant to subsection 30.1(1) of the Food and Drugs Act. (link: https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/authorized/list.html)

According to the manufacturer, PCL Antigen has a test sensitivity of 94.29% and the test kits are suitable for point of care tests. No extra equipment is needed. They are simple to use, and results are available in 10 minutes. Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

View the PCL Antigen test manual video by clicking the link: PCL COVID-19 ANTIBODY TEST

The following certifications have been awarded to these PCL Antigen test kits: CE Certificate, Korea KPMG, FIND Listed, UNGM Supplier. Countries includes the EU, 2 countries in the Middle East, Qatar and UAE, India, Russia, 3 countries in Latin America, Guatemala, Ecuador, and Colombia.

“Datametrex has been given another incredible opportunity to sell an additional medical testing device in Canada with the antigen test, with a supplier with outstanding medical devices in PCL. With the highly contagious new variant, and the second wave and possible third wave of COVID-19 in Canada and throughout the world, Datametrex believes an increase in testing capacity is critical to test and protect people,” said Marshall Gunter, CEO of Datametrex AI Limited.

The Company’s ability to fulfill any purchase order for the PCL Rapid test kits is subject to the availability of inventory at the time of order. Due to the extraordinarily high demand for COVID-19 test, there is volatility in the supply chain and available supply may fluctuate on a daily basis. Datametrex anticipates that it will have little, or no upfront costs associated with importing and selling these test kits.

To read more, click here.

Datametrex $DM.ca $DTMXF Announces Letter of Intent of Telemedicine Company $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 1:34 PM on Tuesday, March 23rd, 2021
This image has an empty alt attribute; its file name is 72321fd3-ab1d-40a2-af37-397a2993ccb4.png
  • Company to acquire 100% of the issued and outstanding share capital of a telemedicine company that is a subscription service that connects patients with providers or doctors in real-time.
  • Datametrex intends to integrate the Target’s platform into the Company’s core AI technology.

Toronto, Ontario–(Newsfile Corp. – March 23, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has entered into a Letter of Intent (the “LOI“) on March 22, 2021, to acquire 100% of the issued and outstanding share capital of a telemedicine company (the “Target”), an arm’s length privately held company, incorporated under the laws of the Province of British Columbia.

Pursuant to its confidentiality obligations, the identity of the Target is confidential and will be subsequently disclosed if the parties enter into a Definitive Agreement (as defined below).

Subject to the completion of satisfactory mutual due diligence within thirty (30) days from the date of the LOI by Datametrex and Target, respectively, pursuant to the terms and conditions of the LOI, Datametrex and the Target will enter into a Definitive Agreement (“Definitive Agreement”).

“The impact of the acquisition of this telemedicine AI business cannot be minimized. The demand for telemedicine continues to be a large area of growth particularly with the current pandemic. We believe that adding this telemedicine element to our existing AI business will drive significant value for our stakeholders,” said Marshall Gunter, Datametrex’s Chief Executive Officer.

The Target is a telemedicine company that is a subscription service that connects patients with providers or doctors in real time. Datametrex intends to integrate the Target’s platform into the Company’s core AI technology.

The Transaction

It is anticipated that the Transaction will be structured as a share acquisition. Datametrex will acquire all of the securities of Target. It is anticipated that the Definitive Agreement will be signed on or before April 15, 2021 or such other date as mutually agreed to by the parties.

Closing of the Transaction is subject to a number of conditions, including but not limited to the following:

  • The Corporation will acquire the Target Shares for an aggregate purchase price of CAD $12 million (the “Purchase Price”). The Purchase Price shall be satisfied through the issuance of an aggregate of 60 million units (the “Consideration Units”). Each Consideration Unit shall comprise one common share in the capital of the Company (a “Consideration Share”) and a common share purchase warrant (a “Consideration Warrant”) in the capital of the Corporation with an exercise price of $0.20 per Consideration Unit; and
  • Each Consideration Unit shall entitle the holder thereof to acquire one common share in the capital of the Corporation at an exercise price of $0.25 per share for a period of 24 months from date of issuance;
  • Issuance of the Consideration Units and its underlying securities shall be subject to the receipt of regulatory approvals including, without limitation, the approval of the TSX Venture Exchange (“TSXV“) and other conditions and will be subject to statutory hold periods under applicable securities legislation;
  • The Board of Directors and shareholders of Target approving the Definitive Agreement and the transfer of the Target shares to the Company in exchange for the payment of the Purchase Price; and
  • The Company and the Target completing and being satisfied with the results of its due diIigence investigations; and
  • The Transaction closing on or before April 15, 2021.

On closing of the Transaction:

  • Target will become a wholly owned subsidiary of the Company.

Datametrex will not assume any debt of the Target and the proposed acquisition of Target is not expected to constitute a fundamental change or result in a change of business for the Company, nor is it expected to result in a change of control of the Company within the meaning of applicable securities laws and the policies of the TSXV.

To read more, click here.

AGORACOM Small Cap 60: Datametrex $DM.ca $DTMXF Social Media Discovery – Fighting Fake News and Disinformation – Fighting #Covid19 $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 1:15 PM on Monday, March 22nd, 2021

VIDEO – Datametrex AI $DM.ca $DTMXF Discusses Company’s M&A Growth Plans For Artificial Intelligence Division $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 5:46 PM on Monday, March 15th, 2021

Datametrex AI Limited has the rare benefit that most small cap companies would only dream of …. 2 successful independent divisions that are each capable of being a company maker.  

The first division is their Artificial Intelligence driven social media monitoring and discovery product … and this isn’t some basic social media monitoring tool for keywords. Clients include Canadian Federal Government, DRDC, Health Canada, United States Air Force and LOTTE (a $2.6B South Korean multinational conglomerate.

The company announced that it has entered into an LOI to acquire 100% of Perspectum Drone Inspection Services Ltd. an arm’s length privately held artificial intelligence drone imaging predictive analytic services company.

Perspectum is a drone based imaging predictive analytics artificial intelligence (AI) services company, currently focusing on environmental and safety predictive analysis. Datametrex intends to expand the Perspectum platform into the Company’s core Cybersecurity business by integrating the Company’s AI with Perspectum.

“The impact of the acquisition of this AI business cannot be minimized. The demand for imaging predictive analytic reporting continues to be a large area of growth. As businesses and countries continue to work towards zero emissions and carbon neutral footprints, we believe that adding this imaging predictive AI element to our existing cybersecurity business will drive significant value for our stakeholders.”, said Marshall Gunter, Datametrex’s Chief Executive Officer.

As a result of the highest level security clearances required to do this level of work, Datametrex was well positioned with deep roots in South Korea to add their second, though unintended division of COVID-19 test kit distribution.  Again, this isn’t some small cap stretch trying to capitalize on a trend for the sake of stock promotion. Rather, when the Canadian Government came calling for assistance in importing and distributing COVID-19 test kits, Datametrex stepped up to the task thanks to its security clearances already in place in both countries.

Since then, the company has signed multiple multi-million dollar COVID-19 test kit supply agreements with mining companies, a $20M CAD agreement with the television and film industry and various educational institutions.  

Sit back, relax and watch this powerful interview with Datametrex CEO Marshall Gunter.